Drug for ocd
Pro Research Analysisby 
Searched over 200M research papers
Drug Treatment for Obsessive-Compulsive Disorder (OCD)
Selective Serotonin Reuptake Inhibitors (SSRIs) for OCD
Selective serotonin reuptake inhibitors (SSRIs) are the first-line pharmacological treatment for OCD. Prolonged administration of SSRIs has been shown to be most effective in reducing OCD symptoms . Studies have demonstrated that SSRIs, including fluoxetine, fluvoxamine, and sertraline, are superior to placebo in reducing obsessive-compulsive symptoms . Although clomipramine, a tricyclic antidepressant, has shown greater improvement rates over placebo compared to SSRIs, direct comparisons indicate similar therapeutic efficacy between clomipramine and SSRIs Piccinelli1995Pigott1999.
Cognitive Behavioral Therapy (CBT) and Exposure and Response Prevention (ERP)
Combining SSRIs with cognitive behavioral therapy (CBT) or exposure and response prevention (ERP) yields better results than either treatment alone . A randomized clinical trial found that adding CBT/ERP to SSRIs was significantly more effective than adding the antipsychotic risperidone or a placebo . Patients receiving CBT/ERP showed greater reductions in OCD severity and higher response rates compared to those receiving risperidone or placebo .
Antipsychotic Augmentation for Refractory OCD
For patients who do not respond adequately to SSRIs alone, augmentation with atypical antipsychotics such as risperidone can be considered. Risperidone has been shown to be more effective than placebo in reducing OCD symptoms when added to SSRIs . However, the addition of other antipsychotics like olanzapine and quetiapine has shown mixed results, with some studies indicating no significant difference from placebo .
Glutamate-Modulating Drugs
Recent research has explored the potential of glutamate-modulating drugs as a therapeutic strategy for OCD. Memantine, an NMDA receptor antagonist, has shown consistent positive effects as an augmentation therapy in OCD patients . Other glutamate-modulating drugs, such as lamotrigine, topiramate, and riluzole, may also provide therapeutic benefits, although further research is needed to confirm their efficacy Marinova2017Marazziti2019. A proof-of-concept study demonstrated that a single dose of ketamine, another NMDA receptor antagonist, could produce rapid anti-obsessional effects lasting up to one week .
Conclusion
The treatment of OCD primarily involves the use of SSRIs, which are effective in reducing symptoms. Combining SSRIs with CBT or ERP enhances treatment outcomes. For refractory cases, augmentation with atypical antipsychotics like risperidone or exploring glutamate-modulating drugs may offer additional benefits. Further research is needed to optimize treatment strategies and explore new therapeutic targets.
Sources and full results
Most relevant research papers on this topic